References: |
1. Page M.K. et al.: . Clinical value of cystatin C determination. Clinica Chim. Acta 297, 67-72
(2000) .
2. Pirttila TJ, Pitkanen A. Cystatin C expression is increased in the hippocampus following
photothrombotic stroke in rat. Neurosci Lett. 2006 Mar 6;395(2):108-13. Epub 2005 Nov 23.
3. Bokenkamp A, Ciarimboli G, Dieterich C. Cystatin C in a rat model of end-stage renal failure.
Ren Fail. 2001 May-Jul;23(3-4):431-8.
4. Nagai A, Ryu JK, Kobayash S, Kim SU. Cystatin C induces neuronal cell death in vivo. Ann N Y
Acad Sci. 2002 Nov;977:315-21.
5. Xu L, Sheng J, Tang Z, Wu X, Yu Y, Guo H, Shen Y, Zhou C, Paraoan L, Zhou J. Cystatin C
prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol
Dis. 2005 Feb;18(1):152-65.
6. Price Ch.P., Finney H. Developments in the assessment of glomerular filtration rate. Clinica
Chimica Acta 297, 55-66 (2000) .
7. Ono S. et al. Increased cystatin C immunoreactivity in the skin in amyotrophic lateral sclerosis.
8. Nicklin M.J.H. and Barrett A.J. Inhibition of cysteine proteinases and dipeptidyl peptidase 1 by
eggwhite cystatin. Biochem J. 223, 245-253 (1984) .
9. Lindahl P., Abrahamson M., Bjork L.: . Interaction of recombinant human cystatin C with the
cysteine proteinase papain and actinidin. Biochem. J. 281, 49-55 (1996) .
10. Roald AB, Aukland K, Tenstad O. Tubular absorption of filtered cystatin-C in the rat kidney. Exp
Physiol. 2004 Nov;89(6):701-7. Epub 2004 Aug 24.
|